Provided by Tiger Trade Technology Pte. Ltd.

ACRES Commercial Realty Corp.

18.74
+0.07000.37%
Volume:4.27K
Turnover:79.89K
Market Cap:136.53M
PE:19.65
High:18.76
Open:18.76
Low:18.70
Close:18.67
52wk High:24.61
52wk Low:16.51
Shares:7.29M
Float Shares:7.29M
Volume Ratio:0.29
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9538
EPS(LYR):1.15
ROE:7.03%
ROA:1.67%
PB:0.32
PE(LYR):16.30

Loading ...

Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Nov 05, 2025

ACRES Commercial Realty Corp. Reports Positive Q3 Earnings

TIPRANKS
·
Nov 01, 2025

Acres Commercial Realty Is Maintained at Market Outperform by Citizens

Dow Jones
·
Oct 31, 2025

ACRES Commercial Realty Corp. price target raised to $24.50 from $23.50 at Citizens JMP

TIPRANKS
·
Oct 31, 2025

ACRES Realty Q3 2025 Earnings Call Summary and Q&A Highlights: Strategic Asset Sales and Book Value Growth

Earnings Call
·
Oct 30, 2025

ACRES Realty (ACR) Earnings Call Transcript

Motley Fool Transcribing
·
Oct 30, 2025

ACRES Commercial Realty Q3 Sales $21.037M Miss $22.151M Estimate.

Benzinga
·
Oct 30, 2025

Acres Commercial Realty reports Q3 net income of $9.8 million

Reuters
·
Oct 30, 2025

Acres Commercial Realty Corp - Reports $9.8 Mln Net Income, $1.34 per Share for Q3

THOMSON REUTERS
·
Oct 30, 2025

Acres Commercial Realty Corp. Reports Results for Third Quarter 2025

THOMSON REUTERS
·
Oct 30, 2025

Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials

GlobeNewswire
·
Oct 29, 2025

Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation

GlobeNewswire
·
Oct 29, 2025

Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025

GlobeNewswire
·
Oct 28, 2025

QYUNS-B (02509): QX002N (Lusekizumab) Phase III Clinical Trial Results for Ankylosing Spondylitis Presented at 2025 ACR Annual Meeting

Stock News
·
Oct 28, 2025

Acrivon Therapeutics’ Phase 1 Study of ACR-2316: Key Updates and Market Implications

TIPRANKS
·
Oct 28, 2025

Acres Commercial Realty Corp expected to post earnings of 11 cents a share - Earnings Preview

Reuters
·
Oct 27, 2025

Tonix Pharmaceuticals presents data on Tonmya at ACR Convergence

TIPRANKS
·
Oct 27, 2025

Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

GlobeNewswire
·
Oct 27, 2025

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence

GlobeNewswire
·
Oct 27, 2025

Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025

GlobeNewswire
·
Oct 27, 2025